Drug intelligence / Profile preview

Fungiwin

Development stage: Unknown
Lead developer: SKM Siddha and Ayurveda Company
Modality: Small Molecules
Administration: Topical, Oral

Overview

Fungiwin is a proprietary Siddha and Ayurvedic formulation developed by SKM Siddha & Ayurveda Company India Ltd. for the treatment of various fungal skin infections. It is available in multiple dosage forms, including a topical cream, oral tablets, and a powder formulation (launched in 2024). The formulation contains a blend of natural ingredients such as Kalonji (*Nigella sativa*), Dhaarrii, Garudaphala, Purified gandhaka (sulfur), and Bakuchi (*Psoralea corylifolia*), which work synergistically to provide relief from itching, irritation, dryness, and inflammation associated with fungal infections. The product is marketed as a natural herbal antifungal treatment based on traditional Indian medicine principles.

Brand names: Fungiwin
Other names: Fungiwin CreamFungiwin TabletFungiwin Powder

Beyond the preview

Go deeper on Fungiwin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungiwin.

Explore the full profile